Signal transduction using nitric oxide and cyclic guanosine monophosphate

JAMA

Volumn 276, Issue 14, 1996, Pages 1189-1192

  Murad, Ferid ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININE DERIVATIVE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) METHYLARGININE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRODRUG; ENZYME INHIBITOR; ISOENZYME;

CELL TYPE; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; ARTICLE; AWARDS AND PRIZES; BIOSYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; HISTORY; HUMAN; PHYSIOLOGY; RESEARCH; UNITED STATES;

ANIMALS; ARGININE; AWARDS AND PRIZES; CYCLIC GMP; ENZYME ACTIVATION; ENZYME INHIBITORS; HISTORY, 20TH CENTURY; HUMANS; ISOENZYMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRODRUGS; RESEARCH; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; UNITED STATES;

EID: 0030577102     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.14.1189     Document Type: Review

References (32)

1. Murad F, ed. Cyclic GMP synthesis, metabolism and function. Adv Pharmacol. 1994;26:1-335.
2. Ignarro L, Murad F, eds. Nitric oxide: biochemistry, molecular biology, and therapeutic implications. Adv Pharmacol. 1995;34:1-516.
3. Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog Horm Res. 1994;49:239-248.
4. Kimura H, Mittal CK, Murad P. Activation of guanylate cyclase from rat liver and other tissues with sodium aride. J Biol Chem. 1975;250:8016-8022.
5. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;78:1-5.
6. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharm Rev. 1987;39:163-196.
7. Murad F, Förstermann U, Nakane M, et al. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Adv Second Messenger Phasphoprotein Res. 1993;28:101-109.
8. Katsuki S, Arnold W, Mittal CK, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucl Res. 1977;3:23-35.
9. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucl Res. 1978;9:145-158.
10. Kimura H, Mittal CK, Murad F. Increases in cyclic GMP levels in brain and liver with sodium azide, an activator of guanylate eyclase. Nature. 1975; 257:700-702.
11. Katsuki S, Murad F. Regulation of cyclic 3′, 5′-adenosine monophosphate and cyclic 3′, 5′-guanosine monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol. 1977;13:330-341.
12. Katsuki S, Arnold WP, Murad F. Effect of sodium nitroprusside, nitroglycerin and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucl Res. 1977;3:239-247.
13. Murad F, Mittal CK, Arnold WP, Braughler JM. Effect of nitro-compound smooth muscle relaxants and other materials on cyclic GMP metabolism: proceedings of the 7th International Congress of Pharmacology, July, 1978, Paris, France. In: Stocklet JC, ed. Advances in Pharmacology and Therapeutics, Volume 3: Ions, Cyclic Nucleotides, Cholinergy. Elmsford, NY: Pergamon Press Inc; 1978:123-132.
14. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′, 5′-monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977; 74:3203-3207.
15. Diamond J, Holmes T. Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium. Can J Physiol Pharmacol. 1975;53:1099-1107.
16. Craven P, DeRubertis F. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide and related activators by heme and heme proteins. J Biol Chem. 1978;253:8433-8443.
17. Ignarro L, Lippton H, Edwards J, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide. J Pharmacol Exp Ther. 1981;218:739-749.
18. Hirata M, Kohse K, Chang CH, Ikebe T, Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem. 1990;265:1268-1273.
19. Murad F, Mittal CK, Arnold WP, Ichihara K, Braughler E, El-Zayat M. Properties and regulation of guanylate cyclase: activation by azide, nitro compounds and hydroxyl radical and effects of hemecontaining proteins. In: Folca G, Paoletti R, eds. Proceedings of the NATO Advanced Study Institute on Cyclic Nucleotides, Italy, 1977: Molecular Biology and Pharmacology of Cyclic Nucleotides. Amsterdam, the Netherlands: Elsevier Science Publishers; 1978:33-42.
20. Braughler JM, Mittal CK, Murad F. Purification of soluble guanylate cyclase from rat liver. Proc Natl Acad Sci U S A. 1979;76:219-222.
21. Braughler JM, Mittal CK, Murad F. Effects of thiols, sugars and proteins on nitric oxide activation of puanylate cyclase. J Biol Chem. 1979;254:12450-12454.
22. Gerzer R, Bohme E, Hoffman B, Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 1981;132:171-174.
23. Ignarro L, Wood K, Wolin M. Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Adv Cyclic Nucl Protein Phosphorylation Res. 1984;17:267-274.
24. Salvameni D, Miska T, Mosferrer J, Siebert K, Currie M, Needleman P. Nitric oxide activates cyclooxygenase enzyme. Proc Natl Acad Sci U S A. 1993;90:7240-7244.
25. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature. 1980;288:373-376.
26. Rapoport RM, Murad F. Agonist-induced endothelial-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ Res. 1983;52: 352-357.
27. Rapoport RM, Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role for cyclic GMP. J Cyclic Nucl Protein Phosphorylation Res. 1983;9:281-296.
28. DeGuici T, Yoshiako M. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J Biol Chem. 1982; 257:10147-10157.
29. Hibbs J, Traintor R, Varrin Z. Macrophage cytoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987;235:473-476.
30. Ishii K, Sheng H, Warner T, Förstermann U, Murad F. A simpie and sensitive bioassay method for detection of EDRF with RFL6 rat lung fibroblasts. Am J Physiol. 1991;261:H598-H603.
31. Ishii K, Gorsky L, Förstermann U, Murad F. Endothelium-derived relaxing factor (EDRF): the endogenous activator of soluble guanylate eyclase in various types of cells. J Appl Cardiol. 1989;4:505-512.
32. Schmidt HHHW, Warner TD, Förstermann U, Murad F. Regulation and subcellular location of nitric oxide synthases in RAW 264.7 macrophanges. Mol Pharmacol 1992;41:615-664.